Literature DB >> 35737216

Different Pathways of Cellular Cholesterol Efflux.

Alexander D Dergunov1, Veronika B Baserova2.   

Abstract

Cholesterol efflux is the first and rate-limiting step of reverse cholesterol transport (RCT) from peripheric cells to the liver. The involvement of high-density lipoprotein (HDL) in RCT determines the atheroprotective properties of HDL. Cholesterol efflux from different membrane pools includes both passive and energy-dependent processes. The first type of route consists of cholesterol desorption from the cell membrane into the unstirred layer adjacent to the cell surface and diffusion in the water phase. Moreover, the selective uptake and facilitated diffusion of cholesterol and cholesteryl ester molecules through the hydrophobic tunnel in the scavenger receptor BI molecule does not require energy consumption. The second type of route includes active cholesterol export by the ATP-binding cassette transporters A1 (ABCA1) and G1 (ABCG1). Several cholesterol acceptors specifically bind cholesterol and phospholipid molecules, and cholesterol binding to the albumin molecule, which acts as a shuttle, significantly increases cholesterol movement between acceptors and red blood cells, thus functioning as a sink for cholesterol. Cholesterol and phospholipid molecules effluxed from macrophages by ABCA1 are accepted exclusively by the lipid-free apolipoprotein apoA-I, which is the major protein moiety of HDL, whereas those effluxed by ABCG1 are accepted by HDL. ABCA1- and ABCG1-mediated cholesterol transport, together with cholesterol diffusion, largely determine cholesterol turnover at the physiological level of intracellular cholesterol. However, at cholesterol overload, ABCA1-mediated efflux prevails over other routes. The exchange of apoA-I between lipid-free and lipid-associated states and the synergism of nascent and mature HDL contribute to cholesterol efflux efficiency. Moreover, extracellular cholesterol deposits and microvesicles may be involved in RCT.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ABCA1; ABCG1; Cholesterol; Cholesterol efflux; HDL kinetic stability; HDL mass and charge heterogeneity; SR-BI; apoA-I

Mesh:

Substances:

Year:  2022        PMID: 35737216     DOI: 10.1007/s12013-022-01081-5

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.989


  93 in total

Review 1.  The exchangeable apolipoproteins in lipid metabolism and obesity.

Authors:  Xin Su; Daoquan Peng
Journal:  Clin Chim Acta       Date:  2020-01-22       Impact factor: 3.786

2.  The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.

Authors:  Alexander D Dergunov; Alexey V Novoselov; Sophie Visvikis; Gerard Siest; Vladimir V Yakushkin; Vladimir Tsibulsky
Journal:  Biol Chem       Date:  2005-05       Impact factor: 3.915

3.  Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36.

Authors:  J Han; D P Hajjar; M Febbraio; A C Nicholson
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

Review 4.  Molecular mechanisms for ABCA1-mediated cholesterol efflux.

Authors:  Lei Chen; Zhen-Wang Zhao; Peng-Hui Zeng; Ying-Jie Zhou; Wen-Jun Yin
Journal:  Cell Cycle       Date:  2022-02-22       Impact factor: 5.173

5.  Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux.

Authors:  Bela F Asztalos; Margarita de la Llera-Moya; Gerard E Dallal; Katalin V Horvath; Ernst J Schaefer; George H Rothblat
Journal:  J Lipid Res       Date:  2005-08-01       Impact factor: 5.922

Review 6.  ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis.

Authors:  Michinori Matsuo
Journal:  J Pharmacol Sci       Date:  2021-12-01       Impact factor: 3.337

7.  Three-dimensional cryoEM reconstruction of native LDL particles to 16Å resolution at physiological body temperature.

Authors:  Vibhor Kumar; Sarah J Butcher; Katariina Öörni; Peter Engelhardt; Jukka Heikkonen; Kimmo Kaski; Mika Ala-Korpela; Petri T Kovanen
Journal:  PLoS One       Date:  2011-05-09       Impact factor: 3.240

8.  Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine.

Authors:  Michael N Trinh; Michael S Brown; Joseph L Goldstein; Jaeil Han; Gonçalo Vale; Jeffrey G McDonald; Joachim Seemann; Joshua T Mendell; Feiran Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-20       Impact factor: 11.205

Review 9.  HDL Is Not Dead Yet.

Authors:  Shuhui Wang Lorkowski; Jonathan D Smith
Journal:  Biomedicines       Date:  2022-01-07
View more
  1 in total

Review 1.  Bidirectional Control between Cholesterol Shuttle and Purine Signal at the Central Nervous System.

Authors:  Daniela Passarella; Maurizio Ronci; Valentina Di Liberto; Mariachiara Zuccarini; Giuseppa Mudò; Carola Porcile; Monica Frinchi; Patrizia Di Iorio; Henning Ulrich; Claudio Russo
Journal:  Int J Mol Sci       Date:  2022-08-04       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.